...
【24h】

Symposium 7

机译:研讨会7.

获取原文
           

摘要

Japan is one of the few countries that has the infrastructure to support drug discovery. Drug discovery isan important industry that will support Japan's future, and is expected to be a driving force for furtherimproving infrastructure and improving medical care.The drug discovery process is based on basicresearch (2-3 years), non-clinical studies (3-5 years), clinical trials (3-7 years) and applications for new drugapproval and approval review (1-2 years). In addition, research on formulation and manufacturing of newdrug is needed.Animal studies are often performed in efficacy, safety and pharmacokinetic studies as nonclinicalstudies. Based on the essential values of efficacy and safety, easy-to-use, security and reliability, andinformation on use form a pyramid of drug value.Therefore, animal testing in drug discovery requiresaccuracy, reproducibility, reliability (GLP etc.), and global applicability. There is also a need for speed formarket launch as soon as possible and social understanding (legal compliance, animal welfare, etc.).Thissymposium was designed to share the current status and proposition of efficacy, safety, pharmacokineticand pharmaceutical research in drug discovery animal research.Animal experiments in drug discovery arevery important for creating new drugs, but there were few opportunities for discussion at JALAS annualmeeting. In recent years, it has been desired to transmit value in order to improve social understanding ofanimal experiments. We hope this symposium will be an opportunity.
机译:日本是少数有基础设施支持药物发现的国家之一。药物发现ISAN重要的行业将支持日本未来,预计将成为进一步的基础设施和改善医疗护理的推动力。药物发现过程基于基础研究(2-3岁),非临床研究(3-5年份),临床试验(3-7岁)和新的药物批准和审批审查的申请(1-2岁)。此外,需要对新液体的制剂和制造进行研究。常规研究通常以非克隆属性的疗效,安全和药代动力学研究进行。基于功效和安全性,易于使用,安全性和可靠性的基本价值,使用易于使用,使用了药物价值的金字塔。因此,药物发现中的动物测试需要准确,可重复性,可靠性(GLP等)和全球适用性。还需要尽快提供速度制造商标和社会理解(法律合规性,动物福利等)。旨在分享药物发现动物研究中的疗效,安全,药代动力学药物研究的现状和主张。药物发现中的实验arevery对于创造新药物很重要,但贾拉斯的讨论很少有机会。近年来,需要传递价值,以改善对自身实验的社会理解。我们希望这个研讨会将是一个机会。

著录项

  • 来源
    《Experimental Animals》 |2020年第supplement期|共5页
  • 作者

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号